Axon Enterprise, Inc. (NASDAQ:AXON) Given Average Rating of “Moderate Buy” by Analysts

Shares of Axon Enterprise, Inc. (NASDAQ:AXON) have earned an average recommendation of “Moderate Buy” from the twelve analysts that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating and eleven have given a buy rating to the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $335.27.

Several research firms have weighed in on AXON. StockNews.com cut Axon Enterprise from a “buy” rating to a “hold” rating in a research report on Thursday, March 14th. Barclays lifted their price target on shares of Axon Enterprise from $308.00 to $381.00 and gave the company an “overweight” rating in a research report on Wednesday, May 8th. Craig Hallum increased their price target on Axon Enterprise from $325.00 to $370.00 and gave the stock a “buy” rating in a research report on Tuesday, May 7th. Robert W. Baird lifted their price objective on Axon Enterprise from $260.00 to $300.00 and gave the company an “outperform” rating in a report on Thursday, February 22nd. Finally, The Goldman Sachs Group increased their target price on Axon Enterprise from $297.00 to $339.00 and gave the stock a “buy” rating in a report on Wednesday, February 28th.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, Director Jeri Williams sold 308 shares of the business’s stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $310.07, for a total transaction of $95,501.56. Following the sale, the director now owns 1,607 shares of the company’s stock, valued at $498,282.49. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, insider Jeffrey C. Kunins sold 43,668 shares of Axon Enterprise stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $309.94, for a total transaction of $13,534,459.92. Following the sale, the insider now directly owns 189,719 shares of the company’s stock, valued at $58,801,506.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jeri Williams sold 308 shares of the company’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $310.07, for a total value of $95,501.56. Following the completion of the transaction, the director now directly owns 1,607 shares of the company’s stock, valued at approximately $498,282.49. The disclosure for this sale can be found here. Insiders sold a total of 87,976 shares of company stock valued at $27,268,201 in the last quarter. Insiders own 6.10% of the company’s stock.

Institutional Investors Weigh In On Axon Enterprise

A number of institutional investors have recently added to or reduced their stakes in AXON. ICA Group Wealth Management LLC bought a new stake in shares of Axon Enterprise in the fourth quarter worth $26,000. Trivant Custom Portfolio Group LLC bought a new stake in shares of Axon Enterprise in the 1st quarter valued at about $31,000. BKM Wealth Management LLC acquired a new stake in shares of Axon Enterprise in the fourth quarter valued at about $32,000. First PREMIER Bank bought a new position in shares of Axon Enterprise during the first quarter worth about $33,000. Finally, Key Financial Inc lifted its stake in shares of Axon Enterprise by 367.6% in the fourth quarter. Key Financial Inc now owns 159 shares of the biotechnology company’s stock worth $41,000 after acquiring an additional 125 shares during the period. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Stock Up 2.0 %

Shares of AXON opened at $285.63 on Monday. The firm has a market cap of $21.56 billion, a P/E ratio of 83.52 and a beta of 0.91. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.55 and a current ratio of 2.91. Axon Enterprise has a 52 week low of $175.37 and a 52 week high of $329.87. The firm’s 50-day simple moving average is $306.23 and its 200 day simple moving average is $274.76.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Friday, May 10th. The biotechnology company reported $1.15 EPS for the quarter, beating the consensus estimate of $0.95 by $0.20. The company had revenue of $460.74 million for the quarter, compared to the consensus estimate of $441.57 million. Axon Enterprise had a return on equity of 11.71% and a net margin of 15.60%. The firm’s revenue for the quarter was up 34.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.51 earnings per share. On average, analysts forecast that Axon Enterprise will post 2.35 earnings per share for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.